Impact of preprocedural high-sensitivity C-reactive protein on contrast-induced nephropathy in patients undergoing

Zhang Jian-Wei1, Zhou Yu-Jie, Cao Shu-Jun

  • 11Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing, China.

Angiology
|March 30, 2013
PubMed

Insights

Pre-procedure high-sensitivity C-reactive protein (hsCRP) levels predict contrast-induced nephropathy (CIN) risk in ST-segment elevation myocardial infarction (STEMI) patients. Higher hsCRP levels correlate with increased CIN incidence after primary percutaneous coronary intervention (p-PCI).

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarkers

Background:

  • Contrast-induced nephropathy (CIN) is a complication following periprocedural myocardial infarction.
  • High-sensitivity C-reactive protein (hsCRP) is an inflammatory marker associated with cardiovascular events.

Purpose of the Study:

  • To evaluate the association between preprocedural hsCRP levels and CIN incidence in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (p-PCI).

Main Methods:

  • Retrospective analysis of 1452 STEMI patients undergoing p-PCI.
  • Patients were stratified into hsCRP quartiles.
  • CIN incidence and inhospital outcomes were compared across quartiles.

Main Results:

  • Overall CIN incidence was 14.6% (212 patients).
  • CIN incidence increased significantly with higher hsCRP quartiles (Q1: 7.44% to Q4: 21.49%; P < .001).
  • Adjusted analysis identified hsCRP >6.50 mg/L as a significant predictor of CIN.

Conclusions:

  • Preprocedural hsCRP is a significant independent predictor of CIN in STEMI patients undergoing p-PCI.
  • Elevated hsCRP levels are associated with increased risk of CIN and inhospital complications.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...